189 related articles for article (PubMed ID: 9045955)
1. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.
Kanai Y; Ushijima S; Tsuda H; Sakamoto M; Sugimura T; Hirohashi S
Jpn J Cancer Res; 1996 Dec; 87(12):1210-7. PubMed ID: 9045955
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis.
Kanai Y; Ushijima S; Tsuda H; Sakamoto M; Hirohashi S
Cancer Lett; 2000 Jan; 148(1):73-80. PubMed ID: 10680595
[TBL] [Abstract][Full Text] [Related]
3. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
[TBL] [Abstract][Full Text] [Related]
5. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
Zhang X; Li HM; Liu Z; Zhou G; Zhang Q; Zhang T; Zhang J; Zhang C
J Gastroenterol; 2013 Jan; 48(1):132-43. PubMed ID: 22766745
[TBL] [Abstract][Full Text] [Related]
7. Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients.
Ho MK; Lee JM; Chan CK; Ng IO
Hum Pathol; 2003 Jul; 34(7):699-705. PubMed ID: 12874766
[TBL] [Abstract][Full Text] [Related]
8. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas.
Kanai Y; Ushijima S; Hui AM; Ochiai A; Tsuda H; Sakamoto M; Hirohashi S
Int J Cancer; 1997 May; 71(3):355-9. PubMed ID: 9139867
[TBL] [Abstract][Full Text] [Related]
9. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.
Tsuda H; Zhang WD; Shimosato Y; Yokota J; Terada M; Sugimura T; Miyamura T; Hirohashi S
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6791-4. PubMed ID: 2168560
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
[TBL] [Abstract][Full Text] [Related]
11. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
Matsumura T; Makino R; Mitamura K
Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
[TBL] [Abstract][Full Text] [Related]
12. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis.
Oh BK; Um TH; Choi GH; Park YN
Int J Cancer; 2011 Feb; 128(4):857-68. PubMed ID: 20473888
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
[TBL] [Abstract][Full Text] [Related]
15. Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma.
Nishida N; Kudo M; Nishimura T; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Yokomichi N; Nagasaka T; Goel A
PLoS One; 2013; 8(9):e72312. PubMed ID: 24023736
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis.
Takai D; Yagi Y; Habib N; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2000 Jul; 30(7):306-9. PubMed ID: 11007163
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10060-5. PubMed ID: 12110732
[TBL] [Abstract][Full Text] [Related]
19. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors.
Tischoff I; Markwarth A; Witzigmann H; Uhlmann D; Hauss J; Mirmohammadsadegh A; Wittekind C; Hengge UR; Tannapfel A
Int J Cancer; 2005 Jul; 115(5):684-9. PubMed ID: 15704097
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
